<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04261868</url>
  </required_header>
  <id_info>
    <org_study_id>IR.SBMU.ORC.REC.1398.024</org_study_id>
    <nct_id>NCT04261868</nct_id>
  </id_info>
  <brief_title>Virtual Reality Game Playing in Amblyopia Therapy</brief_title>
  <official_title>Virtual Reality Game Playing in Amblyopia Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamideh Sabbaghi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: &quot;Amblyopia is a neurodevelopmental disorder in both monocular and binocular
      functions and it extends even beyond the primary visual integration centers&quot;, therefore,
      amblyopia is not a &quot;lazy eye&quot; but it is a &quot;lazy brain&quot;.

      Purpose: The investigators aimed to compare the visual outcome of occlusion therapy with
      virtual reality game playing as a new therapy on amblyopic children.

      Methods: This RCT was performed on 50 children with unilateral amblyopia ,4 to 10 years old.
      They were randomly divided to case and control (each= 25) groups. case group were trained
      binocularly using the virtual reality games through head set for one hour a day, 5 days in a
      week for 4 to 6 weeks. Controls occluded their non- amblyopic eyes, 2, 4 and 6 hours for mild
      (0.2 to 0.3 LogMAR), moderate (0.3 to 0.6 LogMAR) and severe (BCVA &lt; 0.6 LogMAR) amblyopia,
      respectively.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 11, 2020</start_date>
  <completion_date type="Anticipated">June 11, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 11, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Best Corrected Visual Acuity (BCVA)</measure>
    <time_frame>baseline and 6 months after training</time_frame>
    <description>Change from baseline BCVA at 6 months</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Amblyopia</condition>
  <arm_group>
    <arm_group_label>Virtual Reality</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dichoptic playing games with fine stimulation will present to the amblyopic eye.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patching</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non- amblyopic eye will be recommended to patch.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Virtual Reality</intervention_name>
    <description>New treatment for amblyopia therapy using playing games</description>
    <arm_group_label>Virtual Reality</arm_group_label>
    <other_name>No additional intervention</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patching</intervention_name>
    <description>Patching</description>
    <arm_group_label>Patching</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - The best corrected visual acuity worse than 0.3 LogMAR

        Exclusion Criteria:

          -  Patients with abnormal fixation

          -  Patients with neurological problems

          -  Patients with any types of ocular pathologies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hamideh Sabbaghi, PhD</last_name>
    <phone>989120285930</phone>
    <email>sabbaghi.opt@gmail.com</email>
  </overall_contact>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 30, 2020</study_first_submitted>
  <study_first_submitted_qc>February 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2020</study_first_posted>
  <last_update_submitted>February 7, 2020</last_update_submitted>
  <last_update_submitted_qc>February 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Hamideh Sabbaghi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

